WCG
TRAW icon

Weaver Consulting Group’s Traws Pharma TRAW Stock Holding History

Weaver Consulting Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2
Closed – – 944
2020
Q3 		$0 Buy
2
+1
+100% +$247 ﹤0.01% 1044
2020
Q2 		$0 Hold
1
– – ﹤0.01% 1027
2020
Q1 		$0 Hold
1
– – ﹤0.01% 964
2019
Q4 		$0 Hold
1
– – ﹤0.01% 883
2019
Q3 		$1K Hold
1
– – ﹤0.01% 810
2019
Q2 		$1K Hold
1
– – ﹤0.01% 795
2019
Q1 		$1K Buy
+1
New +$1.19K ﹤0.01% 1449

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HWA
Hillcrest Wealth Advisors Hazlet, New Jersey $247M AUM 16.68% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Weaver Consulting Group's TRAW Position: Q4 2020 in Review

Weaver Consulting Group sold out of Traws Pharma (TRAW) in Q4 2020, closing a stake of 2 shares.

Weaver Consulting Group first reported a position in TRAW in Q1 2019 and held it in 7 quarters. The position peaked at $1K in Q3 2019. 33 funds tracked by Wall St. Rank hold TRAW as of Q4 2020.

  • Weaver Consulting Group reported no remaining Traws Pharma position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 2 Traws Pharma shares in Q4 2020.
  • Weaver Consulting Group first reported a position in Traws Pharma in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's Traws Pharma position peaked at $1K in Q3 2019.
  • 33 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.